ObjectiveTo review the research advances about myeloid derived suppressor cells(MDSC)and pancreatic cancer, and explore the future research trends. MethodRelated literatures in recent 5 years from abroad databases(PubMed, Web of Science, and EMBASE)and domestic databases(CNKI, WANFANG, and WEIPU)were collected and reviewed. ResultsThe MDSC was the core of tumor immune regulation network in pancreatic cancer microenvironment, it formed a complicated feedback with the pancreatic cancer and the stellate cells. MDSC could promote the cancerogensis and progression of pancreatic cancer, and the accumulation of MDSC in peripheral blood of pancreatic cancer patient could predict the poor prognosis. However up to now, the literatures about the relation between MDSC and the chemotherapy and metastasis of pancreatic cancer were limited. ConclusionsThe comprehensive therapy by targeting MDSC of pancreatic cancer is promising. However, many issues need to be further investigated.